GENE DIAGNOSIS AND GENE THERAPY OF CHOLESTEROL TRANSPORT AND CHOLESTEROL REVERSE TRANSPORT DISORDERS
GENE DIAGNOSIS AND GENE THERAPY OF CHOLESTEROL TRANSPORT AND CHOLESTEROL REVERSE TRANSPORT DISORDERS
批准号:
07457123
负责人:
MABUCHI Hiroshi
金额:
$3.97万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
LDL-RECEPTOR ABNORMALITIES IN FAMILIAL HYPERCHOLESTEROLEMIA.More than 230 different mutations in the LDL receptor gene have been reported in the world. We have collected 20 homozygotes and more than 1,500 heterozygotes of FH.Nine variants of LDL receptor gene have been identified in our laboratory. Four mutants showed large deletions detected by Southern blot analysis, and 5 mutants were point mutations detected by SSCP analysis and direct sequencing of PCR products. These 9 mutants accounted for only 17.5% of FH.FH Tsuruga showed a point mutation in exon 6 (280 Asp-Tyr). FH Kanazawa-2 showed a point mutaiopn of 395 Arg-Trp. FH Morioka shwoed a point mutation from C to T (395 Arg-Trp) in exon 9.FH Nanao showed 23 stop mutant in exon 2.FH Yokote showed a mutation of 718 stop in exon 15.CHOLESTERYL-ESTER TRANSFER PROTEIN (CETP) DEFICIENCY IN FAMILIAL HYPER-HDL-CHOLESTEROLEMIA.The genomic DNA of patients with CETP deficiency was used as a substrate for amplification of the CETP gene by PC … More R.At the 5'splice donor of intron 14 (position+1) there was a G to A change altering the strictly conserved G-T intron splice donor to A-T.We found two novel mutants of CETP gene. One splice donor site mutant is a thymidine insertion in +3 position in intron 14, which will, again, result in splicing defect. Another new mutant is a missense mutation in exon 15, producing change of aspartic acid into glycine. This mutant is also highly frequent, almost 1 in 10. Thus, these two common mutants produce at least 68 CETP heterozygotes in 718 general subjects, and might raise the HDL-cholesterol levels and reduce coronary heart disease in the Japanese.LCATDEFICIENCY.The proband is 37 male patient, and his CHOL level was 228mg/dl, HDL-C was 34 mg/dl, his LCAT activity was 0%, and the gene analysis showed a point mutant of 30 Ser-Gly.MICROSOMAL TRANSFER PROTEIN (MTP) GENE MUTATION IN ABETALIPOPROTEINEMIA.The proband was 29 male patient, and his CHOL level was 33mg/dl, TG was 0mg/dl, and HDL-C was 28mg/dl. The gene analysis showed a point mutation in the junction of exon 10 and intron 9 (G to A), which would produce splicing abnormalities and no MTP protein. Less
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nohara A,et al.: "Absence of familial defective apolipoprotein B-100 in Japanese patients with familiat hypercholesterolemia" Lancet. 345. 1435- (1995)
Nohara A 等人:“日本家族性高胆固醇血症患者缺乏家族性缺陷载脂蛋白 B-100”《柳叶刀》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kajinami K,Seki H,Takekoshi N,Mabuchi H: "Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography : comparison with electrocardiographic and thallium exercise stress tes
Kajinami K、Seki H、Takekoshi N、Mabuchi H:“使用电子束计算机断层扫描量化冠状动脉钙化来无创预测冠状动脉粥样硬化:与心电图和铊运动负荷测试的比较
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kajinami K,et al.: "Long-term probucol trcatment results in regression of xanhtoms,but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia." Atherosclerosis. 120. 181-187 (1996)
Kajinami K 等人:“长期普罗布考治疗可导致家族性高胆固醇血症杂合子患者黄斑消退,但导致冠状动脉粥样硬化进展。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koizumi J,Haraki T,Yagi K,Inazu A,Kajinami K,Mabuchi H,et al.: "Clinical efficacy of fluvastatin in the long-term treatment of familial hypercholesterolemia." Am J Cardiol. 76. 47A (1995)
Koizumi J、Haraki T、Yagi K、Inazu A、Kajinami K、Mabuchi H 等:“氟伐他汀长期治疗家族性高胆固醇血症的临床疗效”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kajinami K,et al.: "Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam conputed torrography : conparison with electrocardiographic and thallium exercise stress test results." J Am Coll
Kajinami K 等人:“通过使用电子束计算机断层扫描量化冠状动脉钙化来无创预测冠状动脉粥样硬化:与心电图和铊运动负荷测试结果进行比较。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
DEVELOPMENT OF LIGHT WEIGHT Ll_2-Al_3Ti ALLOYS AND FORMATION OF GRADED OXIDATION-RESISTANT LAYER FOR TiAl ALLOYS.
-
批准号:12450285
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.14万
-
财政年份:2000
-
负责人:MABUCHI Hiroshi
-
依托单位:
Study on Phase Stability of Light Weight-High Temperature LlィイD22ィエD2-AlィイD23ィエD2Ti Based Alloys.
-
批准号:10650695
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:MABUCHI Hiroshi
-
依托单位:
MOLECULAR GENETICS OF CHOLESTEROL METABOLIC PATHWAY AND TREATMENT OF ATHEROSCLEEROSIS
-
批准号:09307010
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$17.6万
-
财政年份:1997
-
负责人:MABUCHI Hiroshi
-
依托单位:
Development of Light Weight-High Temperature Structural L1_2 Compounds in Al_3Ti-Base Alloys.
-
批准号:07650822
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:MABUCHI Hiroshi
-
依托单位:
MOLECULAR GENETICS OF CHOLESTEROL TRANSPORT AND CHOLESTEROL REVERSE TRANSPORT DISORDERS
-
批准号:04454235
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1992
-
负责人:MABUCHI Hiroshi
-
依托单位:
Molecular Genetics of Familial Hyperlipidemias
-
批准号:63480187
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1988
-
负责人:MABUCHI Hiroshi
-
依托单位:
Studies on apolipoprotein B and E genes in familial hyperlipidemias
-
批准号:59480198
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.56万
-
财政年份:1984
-
负责人:MABUCHI Hiroshi
-
依托单位:
海外基金